Literature DB >> 29686563

Pulmonary lymphangioleiomyomatosis associated with aggressive renal angiomyolipoma.

Allison Cooper1, Laura Baugh1, Shannon Kelley1, Howard Huang2, Joseph Guileyardo1.   

Abstract

Lymphangioleiomyomatosis (LAM) is a rare cystic pulmonary disease that may occur in association with mutations in the tuberous sclerosis genes or arise sporadically. The histologic hallmark of the disease is the "LAM" cell, a spindled to epithelioid smooth muscle-like cell that bears morphologic and immunohistochemical resemblance to the perivascular epithelioid cell tumors (PEComas). The origin of the "LAM" cell is unknown; emerging theories suggest that a member of the PEComa family, the renal angiomyolipoma, may be the primary source and that both LAM and angiomyolipomas are associated with the genetic syndrome tuberous sclerosis. We present a young woman with LAM with an aggressive renal angiomyolipoma confirmed at autopsy.

Entities:  

Keywords:  Angiomyolipoma; lymphangioleiomyomatosis; perivascular epithelioid cell tumor; tuberous sclerosis

Year:  2018        PMID: 29686563      PMCID: PMC5903512          DOI: 10.1080/08998280.2017.1391038

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  12 in total

1.  European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis.

Authors:  S R Johnson; J F Cordier; R Lazor; V Cottin; U Costabel; S Harari; M Reynaud-Gaubert; A Boehler; M Brauner; H Popper; F Bonetti; C Kingswood
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

2.  Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosis.

Authors:  Yang Sun; Erik Zhang; Taotao Lao; Ana M Pereira; Chenggang Li; Li Xiong; Tasha Morrison; Kathleen J Haley; Xiaobo Zhou; Jane J Yu
Journal:  Horm Cancer       Date:  2014-07-29       Impact factor: 3.869

3.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis.

Authors:  E C Harknett; W Y C Chang; S Byrnes; J Johnson; R Lazor; M M Cohen; B Gray; S Geiling; H Telford; A E Tattersfield; R B Hubbard; S R Johnson
Journal:  QJM       Date:  2011-07-15

5.  Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis.

Authors:  Toshio Kumasaka; Kuniaki Seyama; Keiko Mitani; Sanae Souma; Satoko Kashiwagi; Akira Hebisawa; Teruhiko Sato; Hajime Kubo; Kiyoshi Gomi; Kazutoshi Shibuya; Yoshinosuke Fukuchi; Koichi Suda
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

6.  Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.

Authors:  Denise M Crooks; Gustavo Pacheco-Rodriguez; Rosamma M DeCastro; J Philip McCoy; Ji-an Wang; Fumiyuki Kumaki; Thomas Darling; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

Review 7.  Metastasis of benign tumor cells in tuberous sclerosis complex.

Authors:  Elizabeth Petri Henske
Journal:  Genes Chromosomes Cancer       Date:  2003-12       Impact factor: 5.006

8.  Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells.

Authors:  Jane J Yu; Victoria A Robb; Tasha A Morrison; Eric A Ariazi; Magdalena Karbowniczek; Aristotelis Astrinidis; Chunrong Wang; Lisa Hernandez-Cuebas; Laura F Seeholzer; Emmanuelle Nicolas; Harvey Hensley; V Craig Jordan; Cheryl L Walker; Elizabeth P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

Review 9.  Lymphangioleiomyomatosis - a wolf in sheep's clothing.

Authors:  Elizabeth P Henske; Francis X McCormack
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

10.  Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial.

Authors:  D Mark Davies; Petrus J de Vries; Simon R Johnson; Deborah L McCartney; Jane A Cox; Andreas L Serra; Peter C Watson; Christopher J Howe; Tim Doyle; Kate Pointon; Justin J Cross; Anne E Tattersfield; J Chris Kingswood; Julian R Sampson
Journal:  Clin Cancer Res       Date:  2011-04-27       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.